Product Detail

Brand Gardasil® 9

Manufacturer Merck

Country of Origin United States

Application Human Papillomavirus Vaccine (HPV)

Container Type Prefilled Syringe

Dosage Form Injection

Generic Drug Code 37568

Generic Drug Name Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free

NDC Number 00006412102

Product Dating McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements Requires Refrigeration

Strength 20 mcg - 60 mcg / 0.5 mL

Type Intramuscular

UNSPSC Code 51201649

User Indicated for People 9 to 45 Years of Age

Volume 0.5 mL

• GARDASIL 9 is a non-infectious recombinant 9-valent vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58

• Each 0.5-mL dose contains approximately 30 mcg of HPV Type 6 L1 protein, 40 mcg of HPV Type 11 L1 protein, 60 mcg of HPV Type 16 L1 protein, 40 mcg of HPV Type 18 L1 protein, 20 mcg of HPV Type 31 L1 protein, 20 mcg of HPV Type 33 L1 protein, 20 mcg of HPV Type 45 L1 protein, 20 mcg of HPV Type 52 L1 protein, and 20 mcg of HPV Type 58 L1 protein

• Administer GARDASIL 9 intramuscularly as a 0.5-mL dose at the following schedule: 0, 2 months, 6 months

• Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL 9 protects only against those vulvar, vaginal, and anal cancers caused by HPV 16, 18, 31, 33, 45, 52 and 58